Hunan Ouya Pharmaceutical Co., Ltd
About Ouya
Hunan Ouya Pharmaceutical Co., Ltd
Hunan Ouya, an established pharmaceutical company, is engaged in the development and manufacturing of pharmaceutical intermediates and APIs for the generic industry. Within a decade since inception in 2007, Hunan Ouya has emerged as a trusted partner in the generic industry across Asia, Europe and other markets.   Hunan Ouya’s portfolio is spread across more than 10 therapeutic segments and specialize in development and manufacturing of pharmaceutical intermediates for Oncology and Migraine.   Hunan Ouya obtained the Drug Manufacturing License in 2019. Our manufacturing facilities are state-of-the-art, multipurpose facilities that comply with cGMP standards and meet the requirements of our customers. We are establishing 7 new GMP workshops and 1 special reaction production line in 2020.   Research and innovation is the mainstay of Hunan Ouya’s operations. We owned 18 independent intellectual property rights, submitted more than 40 invention patent applications to the State Intellectual Property Office, and were recognized as "Hunan Little Giant Enterprise" and "Hunan High-tech Enterprise".   Hunan Ouya Pharmaceutical Co., Ltd. will adhere to the concept of "science and technology as the basis, environmental protection and health", constantly develop innovative products for our domestic and foreign customers.
more about
Product Categories
We supply the world with quality and cost effective active pharmaceutical ingredients and pharmaceutical intermediates which enable our customers to improve their patients’ quality of life.
Hot Products
2007

established

Hunan Ouya Pharmaceutical Co., Ltd

8
GMP Production Workshop
300MT
MT
Capacity
40
+
Patent
28
+
Years Experience
Our Service
The Contract Developing and Manufacturing Services (CDMO) is our fastest growing business segment in Hunan Ouya. The company's CDMO is one of the leading cost-competitive and quality manufacturing hubs for many important pharma companies.
They Trust Us
ABBVIE
Macleod
hetero
MSN
BIOCON
恒瑞
Thermofisher
Latest News
The CPhI China will be postponed to 21-23 June, 2022
18 Oct
The CPhI China will be postponed to 21-23 June, 2022
Due to the sudden and unexpected rise in COVID-19 cases in Shanghai and local cities, the in-person CPhI & P-MEC China event will be postponed from 16-18 December 2021 to 21-23 June 2022.This...
view more
Recognition party for company's first approved API Olmesartan Medoxomil
21 Jun
Recognition party for company's first approved API Olmesartan Medoxomil
On 1st June , 2021, Hunan Ouya Pharmaceutical Co., Ltd. held an awards and commendation meeting for company first approved API. All departments reviewed the project history and looked forward to the f...
view more
Feel the revolutionary culture and inherit the revolutionary spirit
18 May
Feel the revolutionary culture and inherit the revolutionary spirit
The  year 2021 is the 100th anniversary of the founding of the Communist Party of China. In order to truly experience the revolutionary culture, carry forward the revolutionary traditional spirit...
view more
Important Paxlovid Updates
29 Apr
Important Paxlovid Updates
Important Information About Paxlovid Paxlovid (nirmatrelvir/PF-07321332 and ritonavir) is authorized for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adult and pediatric pa...
view more
Holiday Notice
29 Apr
Holiday Notice
Dear Customers, We will be off from 30th April to 4th May in order to celebrate Labor's Day. If you have any questions about products and production during the holidays, please contact your dedicated ...
view more
Leave A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.

Home

Products

skype

whatsapp